Google Alert - program

	program As-it-happens update ⋅ September 27, 2023
	NEWS
	Takeda Puts Nearly $600M on the Line for AcuraStem's ALS Program | BioSpace BioSpace In return, the Japanese multinational pharma will gain access to AcuraStem's PIKFYVE program, which includes AS-202, an investigational antisense ... Flag as irrelevant
See more results | Edit this alert

You have received this email because you have subscribed to Google Alerts. Unsubscribe | View all your alerts

Receive this alert as RSS feed

Send Feedback